메뉴 건너뛰기




Volumn 67, Issue 2, 2012, Pages 415-421

Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis

Author keywords

Benzimidazole; Ciprofloxacin; Drug resistance; Non replicating bacteria; Non tuberculous mycobacteria; Novobiocin; Topoisomerase

Indexed keywords

AB 1; BENZIMIDAVIR; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ISONIAZID; NOVOBIOCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; UNCLASSIFIED DRUG;

EID: 84855838599     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr449     Document Type: Article
Times cited : (95)

References (20)
  • 1
    • 77952339902 scopus 로고    scopus 로고
    • Slow elimination of multidrug-resistant tuberculosis
    • 3ra8
    • Dye C, Williams BG. Slow elimination of multidrug-resistant tuberculosis. Sci Transl Med 2009; 1: 3ra8.
    • (2009) Sci Transl Med , vol.1
    • Dye, C.1    Williams, B.G.2
  • 2
    • 1642537638 scopus 로고    scopus 로고
    • Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis
    • Nuermberger EL, Yoshimatsu T, Tyagi S et al. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2004; 169: 421-6.
    • (2004) Am J Respir Crit Care Med , vol.169 , pp. 421-426
    • Nuermberger, E.L.1    Yoshimatsu, T.2    Tyagi, S.3
  • 3
    • 63349091494 scopus 로고    scopus 로고
    • Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
    • Conde MB, Efron A, Loredo C et al. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet 2009; 373: 1183-9.
    • (2009) Lancet , vol.373 , pp. 1183-1189
    • Conde, M.B.1    Efron, A.2    Loredo, C.3
  • 4
    • 67650046677 scopus 로고    scopus 로고
    • Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression
    • Kaur P, Agarwal S, Datta S. Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PLoS One 2009; 4: e5923.
    • (2009) PLoS One , vol.4
    • Kaur, P.1    Agarwal, S.2    Datta, S.3
  • 5
    • 51849112827 scopus 로고    scopus 로고
    • Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships
    • Charifson PS, Grillot A-L, Grossman TH et al. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. J Med Chem 2008; 51: 5243-63.
    • (2008) J Med Chem , vol.51 , pp. 5243-5263
    • Charifson, P.S.1    Grillot, A.-L.2    Grossman, T.H.3
  • 6
    • 33846582343 scopus 로고    scopus 로고
    • Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds
    • Grossman TH, Bartels DJ, Mullin S et al. Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds. Antimicrob Agents Chemother 2007; 51: 657-66.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 657-666
    • Grossman, T.H.1    Bartels, D.J.2    Mullin, S.3
  • 7
    • 79951996244 scopus 로고    scopus 로고
    • A high-throughput fluorescence polarization assay for inhibitors of gyrase B
    • Glaser BT, Malerich JP, Duellman SJ et al. A high-throughput fluorescence polarization assay for inhibitors of gyrase B. J Biomol Screen 2011; 16: 230-8.
    • (2011) J Biomol Screen , vol.16 , pp. 230-238
    • Glaser, B.T.1    Malerich, J.P.2    Duellman, S.J.3
  • 8
    • 34547112538 scopus 로고    scopus 로고
    • Mycobacterium tuberculosis DNA gyrase as a target for drug discovery
    • Mdluli K, Ma Z. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infect Disord Drug Targets 2007; 7: 159-68.
    • (2007) Infect Disord Drug Targets , vol.7 , pp. 159-168
    • Mdluli, K.1    Ma, Z.2
  • 9
    • 0030903133 scopus 로고    scopus 로고
    • Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
    • Collins L, Franzblau SG. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004-9.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 1004-1009
    • Collins, L.1    Franzblau, S.G.2
  • 10
    • 0000753290 scopus 로고
    • Antimicrobial susceptibility testing
    • Henry DI, ed. Washington, DC: American Society for Microbiology
    • Hindler J. Antimicrobial susceptibility testing. In: Henry DI, ed. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology, 1992.
    • (1992) Clinical Microbiology Procedures Handbook
    • Hindler, J.1
  • 11
    • 0038601510 scopus 로고    scopus 로고
    • Synergy, antagonism, and what the chequerboard puts between them
    • Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 1
    • Odds, F.C.1
  • 12
    • 34247143197 scopus 로고    scopus 로고
    • Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis
    • Cho SH, Warit S, Wan B et al. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 1380-5.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 1380-1385
    • Cho, S.H.1    Warit, S.2    Wan, B.3
  • 13
    • 84855835041 scopus 로고    scopus 로고
    • Isolation of DNA from Mycobacterium tuberculosis
    • Parish T, Stoker NG, eds. New York: Humana Press
    • Van Helden PD, Victor TC, Warren RM et al. Isolation of DNA from Mycobacterium tuberculosis. In: Parish T, Stoker NG, eds. Mycobacterium tuberculosis protocols. New York: Humana Press, 2001; 19-30.
    • (2001) Mycobacterium tuberculosis protocols , pp. 19-30
    • Van Helden, P.D.1    Victor, T.C.2    Warren, R.M.3
  • 14
    • 0023792919 scopus 로고
    • Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines
    • Scudiero DA, Shoemaker RH, Paull KD et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48: 4827-33.
    • (1988) Cancer Res , vol.48 , pp. 4827-4833
    • Scudiero, D.A.1    Shoemaker, R.H.2    Paull, K.D.3
  • 15
    • 0031105464 scopus 로고    scopus 로고
    • DNA gyrase as a drug target
    • Maxwell A. DNA gyrase as a drug target. Trends Microbiol 1997; 5: 102-9.
    • (1997) Trends Microbiol , vol.5 , pp. 102-109
    • Maxwell, A.1
  • 16
    • 77957908236 scopus 로고    scopus 로고
    • Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase
    • Piton J, Petrella S, Delarue M et al. Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase. PLoS One 2010; 5: e12245.
    • (2010) PLoS One , vol.5
    • Piton, J.1    Petrella, S.2    Delarue, M.3
  • 17
    • 0035940515 scopus 로고    scopus 로고
    • Comprehensive identification of conditionally essential genes in mycobacteria
    • Sassetti CM, Boyd DH, Rubin EJ. Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci USA 2001; 98: 12712-7.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 12712-12717
    • Sassetti, C.M.1    Boyd, D.H.2    Rubin, E.J.3
  • 18
    • 0032504252 scopus 로고    scopus 로고
    • Topoisomerase IV catalysis and the mechanism of quinolone action
    • Anderson VE, Gootz TD, Osheroff N. Topoisomerase IV catalysis and the mechanism of quinolone action. J Biol Chem 1998; 273: 17879-85.
    • (1998) J Biol Chem , vol.273 , pp. 17879-17885
    • Anderson, V.E.1    Gootz, T.D.2    Osheroff, N.3
  • 19
    • 58149182735 scopus 로고    scopus 로고
    • TB database: an integrated platform for tuberculosis research
    • Reddy TB, Riley R, Wymore F et al. TB database: an integrated platform for tuberculosis research. Nucleic Acids Res 2009; 37: D499-508.
    • (2009) Nucleic Acids Res , vol.37
    • Reddy, T.B.1    Riley, R.2    Wymore, F.3
  • 20
    • 0037311481 scopus 로고    scopus 로고
    • Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis
    • Hu Y, Coates AR, Mitchison DA. Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 653-7.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 653-657
    • Hu, Y.1    Coates, A.R.2    Mitchison, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.